Not Medicare Enrolled

Dr. Shelley Szabel

Medical Oncology · Orlando, FL
Low-engagement
2501 N ORANGE AVE STE 689, Orlando, FL 32804
4073032024
In practice since 2019 (7 years)
NPI: 1356807481 verify on NPPES ↗
Moderate
DATA COVERAGE
Data in 2 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Szabel from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Szabel? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Szabel

Dr. Shelley Szabel is a medical oncology specialist in Orlando, FL, with 7 years of NPI registration.

Between the years covered by Open Payments, Dr. Szabel received a total of $2,037 from 16 pharmaceutical and/or device companies across 48 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in medical oncology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Szabel is Moderate — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 7 years in practice $2,037 industry payments

Industry Payment Transparency

Open Payments through 2024 ↗
$2,037
Total received (2021-2024)
Avg $509/year across 4 years
Bottom 31% in FL for medical oncology
16
Companies
48
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$2,037 (100.0%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$953
2023
$546
2022
$373
2021
$165

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Daiichi Sankyo Inc.
$531
Janssen Biotech, Inc.
$369
E.R. Squibb & Sons, L.L.C.
$268
Incyte Corporation
$250
Celgene Corporation
$161
Dendreon Pharmaceuticals LLC
$150
Novocure Inc.
$69
AstraZeneca Pharmaceuticals LP
$40
Pharmacosmos Therapeutics Inc.
$37
Blueprint Medicines Corporation
$33
Alexion Pharmaceuticals, Inc.
$26
ABBVIE INC.
$25
GENZYME CORPORATION
$24
Takeda Pharmaceuticals U.S.A., Inc.
$24
Grifols USA, LLC
$16
Novartis Pharmaceuticals Corporation
$15
Top 3 companies account for 57.3% of total payments
Associated products mentioned in payments ›
AYVAKIT · DARZALEX · ENHERTU · ENJAYMO · ERLEADA · Enhertu · Gamunex-C · INJECTAFER · JAKAFI · KISQALI · MONOFERRIC · NINLARO · OPDIVO · Optune · PEMAZYRE · PROVENGE · Pomalyst · REBLOZYL · RYBREVANT · ULTOMIRIS · VENCLEXTA
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Looking for a medical oncology specialist in Orlando?
Compare medical oncologists in the Orlando area by procedure volume, costs, and industry payment transparency.
Browse medical oncologists nearby

Geographic Context

Medical oncologists within 10 mi
24
Per 100K population
1.7
County median income
$77,011
Nearest hospital
ASPIRE HEALTH PARTNERS
3.0 mi

Data Sources

Provider Registry ✓ NPPES Weekly updates
Medicare Enrollment — Not enrolled N/A
Practice Data — No data N/A
Industry Payments ✓ Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 2 of 4 available federal datasets, with a Data Coverage level of Moderate. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Szabel is a medical oncology specialist, with low-engagement industry engagement.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Does Dr. Szabel receive payments from pharmaceutical companies?
Yes. Dr. Szabel received a total of $2,037 from 16 companies across 48 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
What does Data Coverage mean?
Data Coverage (currently Moderate for Dr. Szabel) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →

Explore related providers

Same specialty & city
Medical Oncologists in Orlando
Browse medical oncologists in Orlando ranked by procedure volume and transparency data.
Highest volume
Top Medical Oncologists in FL
Medical oncologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Medical Oncologists in FL
Which FL medical oncologists receive the most from drug and device companies.
By company
Daiichi Sankyo Inc. Payments to Doctors
See all physicians who received payments from Daiichi Sankyo Inc.
By company
Janssen Biotech, Inc. Payments to Doctors
See all physicians who received payments from Janssen Biotech, Inc.
By company
E.R. Squibb & Sons, L.L.C. Payments to Doctors
See all physicians who received payments from E.R. Squibb & Sons, L.L.C.
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →